ABATE, FILOMENA
 Distribuzione geografica
Continente #
AS - Asia 2.664
NA - Nord America 364
EU - Europa 346
SA - Sud America 67
OC - Oceania 13
AF - Africa 2
Totale 3.456
Nazione #
HK - Hong Kong 2.462
US - Stati Uniti d'America 351
IT - Italia 141
RU - Federazione Russa 98
SG - Singapore 94
BR - Brasile 63
CN - Cina 39
VN - Vietnam 39
DE - Germania 30
IE - Irlanda 18
GB - Regno Unito 14
KR - Corea 14
NL - Olanda 13
SE - Svezia 12
AU - Australia 8
CA - Canada 7
AT - Austria 6
FI - Finlandia 6
IN - India 5
NZ - Nuova Zelanda 5
CZ - Repubblica Ceca 4
MX - Messico 4
UZ - Uzbekistan 3
AR - Argentina 2
BD - Bangladesh 2
IQ - Iraq 2
PL - Polonia 2
TR - Turchia 2
UA - Ucraina 2
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
IR - Iran 1
KE - Kenya 1
KW - Kuwait 1
MA - Marocco 1
Totale 3.456
Città #
Hong Kong 2.462
Chandler 60
Princeton 53
Singapore 51
West Jordan 37
Dong Ket 34
Naples 34
Ashburn 32
Dublin 17
Beijing 15
Moscow 15
Munich 15
Lecce 14
Nuremberg 10
Los Angeles 9
Andover 7
Santa Clara 7
Milan 6
Rome 6
Wilmington 6
Amsterdam 5
Ann Arbor 5
Genoa 5
Seattle 5
Boardman 4
Bologna 4
Brno 4
Curitiba 4
Dallas 4
New York 4
Romano di Lombardia 4
Sydney 4
Toronto 4
Washington 4
Belo Horizonte 3
Boston 3
Council Bluffs 3
Jacksonville 3
Marigliano 3
Menlo Park 3
Norwalk 3
Pune 3
Rio de Janeiro 3
São Paulo 3
Turku 3
Assago 2
Auckland 2
Brasília 2
Casavatore 2
Charlotte 2
Chełmża 2
College Park 2
Eboli 2
Fortaleza 2
Gaeta 2
Helsinki 2
Mauá 2
Mexico City 2
Montreal 2
Monza 2
Nürnberg 2
Pittsburgh 2
Redwood City 2
Shanghai 2
Tashkent 2
The Dalles 2
Turin 2
Vienna 2
Abaetetuba 1
Adelaide 1
Agadir 1
Alajuela 1
Ananindeua 1
Andrelândia 1
Annapolis 1
Arapiraca 1
Araxá 1
Arcoverde 1
As Sālimīyah 1
Atlanta 1
Ayr 1
Balbriggan 1
Baltimore 1
Belo Jardim 1
Betim 1
Birmingham 1
Bradford 1
Brampton 1
Brooklyn 1
Bình Dương 1
Calmon 1
Cambuí 1
Campina Grande do Sul 1
Campinas 1
Campo Grande 1
Cerrillo de Catemu 1
Chennai 1
Christchurch 1
Cleveland 1
Columbus 1
Totale 3.061
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 993
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 675
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 644
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 133
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 109
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 97
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 96
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 86
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 73
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 64
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 62
Midbrain MRI assessments in progressive supranuclear palsy subtypes 60
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 57
Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndrome 43
Agreement between Optoelectronic System and Wearable Sensors for the Evaluation of Gait Spatiotemporal Parameters in Progressive Supranuclear Palsy 42
Performing a short sway to distinguish Parkinsonisms 39
Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stages 36
The “zig-zag” sign in Progressive Supranuclear Palsy 34
Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy 30
Frequency and imaging correlates of neuropsychiatric symptoms in Progressive Supranuclear Palsy 28
Temporal muscle thickness and survival in patients with amyotrophic lateral sclerosis 23
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 21
Brittle response to levodopa as a marker of Parkinson’s disease phenotype characterized by heavy motor and non-motor burden 20
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy 20
Direct Current Stimulation of Prefrontal Cortex Is Not Effective in Progressive Supranuclear Palsy: A Randomized Trial 19
Totale 3.504
Categoria #
all - tutte 8.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.717


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 2 8 0 5 0 3 0 0 34
2021/202290 2 1 0 8 7 0 2 3 10 10 8 39
2022/2023159 15 22 16 14 8 23 8 14 24 2 9 4
2023/2024196 4 13 9 17 11 22 12 9 16 50 12 21
2024/2025461 3 3 4 31 33 42 114 30 50 31 56 64
2025/20262.538 2.283 255 0 0 0 0 0 0 0 0 0 0
Totale 3.504